Phase 1 Study of Terameprocol (EM-1421) in Patients With Leukemia

Clinical trial NCT00664677 · TERMINATED

Trial details

NCT number: NCT00664677
Sponsor: Erimos Pharmaceuticals
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Leukemias Acute Myeloid Leukemia (AML)Acute Lymphocytic Leukemia (ALL)Adult T Cell Leukemia (ATL)Chronic Myeloid Leukemia (CML-BP)Chronic Lymphocytic Leukemia (CLL)Myelodysplastic Syndrome (MDS)Chronic Myelomonocytic Leukemia (CMML)

Start date: 2007-08-01
Primary completion: 2009-03-01
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.